Teva Pharmaceutical Industries (TEVA) Net Shares Issued and Repurchased (2009 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported Net Shares Issued and Repurchased for 9 consecutive years, with $7.0 million the latest figure, recorded in Q4 2018.

• For the quarter ending Q4 2018, Net Shares Issued and Repurchased changed N/A year-over-year to $7.0 million; the trailing twelve-month figure through Dec 2018 stood at $7.0 million (changed N/A YoY), and the FY2018 full-year result was $7.0 million, changed N/A from the prior year.
• Net Shares Issued and Repurchased improved to $7.0 million in Q4 2018 per TEVA's latest filing, from $1.4 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $7.0 million in Q4 2018 and bottomed at -$1.0 million in Q4 2015.
• Historically, Net Shares Issued and Repurchased has averaged $2.2 million across 4 years, with a median of $1.3 million in 2014.
• The sharpest annual moves came in 2015 and 2016: Net Shares Issued and Repurchased sank 181.59% in 2015, then jumped 234.44% in 2016.
• Over 4 years, Net Shares Issued and Repurchased stood at $1.3 million in 2014, then tumbled by 181.59% to -$1.0 million in 2015, then surged by 234.44% to $1.4 million in 2016, then surged by 409.41% to $7.0 million in 2018.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $7.0 million, $1.4 million, and -$1.0 million for Q4 2018, Q4 2016, and Q4 2015 respectively.